Why AbbVie Stock Flew Higher on Friday
A bellwether stock in the lately rather up-and-down pharmaceutical sector, (NYSE: ABBV) finished the trading week in style. The company's shares closed more than 3% higher in price thanks in no small part to a clutch of post-earnings analyst price-target increases. With that performance, Abbvie crushed the S 500 index, which dived by 1.6% on the day.
As typically happens when a publicly traded company posts better-than-expected quarterly results, those pundits made the positive changes a day after AbbVie published its estimates-besting second-quarter figures.
Image source: Getty Images.
Source Fool.com
AbbVie Inc. Stock
€198.60
-0.200%
With 42 Buy predictions and not a single Sell prediction AbbVie Inc. is an absolute favorite of our community.
With a target price of 205 € there is a slightly positive potential of 3.22% for AbbVie Inc. compared to the current price of 198.6 €.
